Dexcom G6 Transmitter
Payments companies reported to CMS as associated with Dexcom G6 Transmitter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dexcom G6 Transmitter, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dexcom G6 Transmitter
These are the largest totals companies reported as associated with Dexcom G6 Transmitter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sina Tebi | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $3,402.35 |
| Thomas Grace | Findlay, OH | Family Medicine | $3,123.43 |
| Cristina Marco | Mission Hills, CA | Family | $3,113.67 |
| Vijayveer Pamar | San Antonio, TX | Endocrinology, Diabetes & Metabolism | $2,479.84 |
| Firas Akhrass | San Antonio, TX | Endocrinology, Diabetes & Metabolism | $2,416.89 |
| Aaron King | San Antonio, TX | Family Medicine | $2,146.01 |
| Tatiana Sams | Campbell, CA | Endocrinology, Diabetes & Metabolism | $2,024.21 |
| Febbie Phiri | San Antonio, TX | Family | $2,021.66 |
| Tony Kastoon | San Bernardino, CA | Internal Medicine | $2,021.21 |
| Olga Calof | San Pedro, CA | Endocrinology, Diabetes & Metabolism | $1,963.09 |
Prescribed Dexcom G6 Transmitter?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.